Interestingly, MetS rats treated with the AT1 receptor blocker candesartan for four weeks showed a significant reduction in the number of EVs captured by the ExoView (7.93 × 103 ± 563.44) (Figure 1C). The gene discussed is AGTR1; the disease is metabolic syndrome.